Piscataway, NJ, January 6, 2022–Camber Pharmaceuticals is pleased to announce the addition of the Amphetamine IR Tablets to their current portfolio.
Amphetamine IR Tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and Narcolepsy.
Amphetamine IR Tablets from Camber are available in 5, 7.5, 10, 12.5, 15, 20 and 30 mg strengths. All strengths are available in 100 count bottles.
To find out more about Amphetamine IR Tablets please visit https://www.camberpharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].